Innate Pharma SA - SPONSORED ADS (IPHA)

Historical Portfolio Holders from Q4 2019 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q2 2024
242K
Holdings value Q2 2024
$469K
Value change Q2 2024
-$47.2K
Grand Portfolio weight change Q2 2024
0%
Number of holders
8
Number of buys Q2 2024
3
Number of sells Q2 2024
-4
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 242K $469K -$47.2K $1.94 8
2024 Q1 254K $731K +$366K $2.88 9
2023 Q4 129K $361K -$535K $2.80 8
2023 Q3 318K $806K +$244K $2.53 8
2023 Q2 412 $1K -$171K $2.43 1
2023 Q1 397K $1.13M -$11.7K $2.85 8
2022 Q4 399K $1.49M -$839K $3.73 9
2022 Q3 779K $1.56M -$11.1K $2.00 8
2022 Q2 954K $2.58M -$72.8K $2.70 11
2022 Q1 952K $3.2M -$1.82M $3.36 12
2021 Q4 1.2M $5.49M +$1.08M $4.56 14
2021 Q3 943K $5.82M +$5.27M $6.17 18
2021 Q2 89.5K $296K -$324K $3.30 5
2021 Q1 176K $760K -$5.09M $4.32 7
2020 Q4 1.4M $5.71M -$1.12M $4.09 4
2020 Q3 1.68M $6.65M -$6.06M $3.90 6
2020 Q2 2.87M $20.3M -$29.6M $7.00 7
2020 Q1 7.34M $49M -$2.48M $6.68 9
2019 Q4 7.71M $49.7M +$49.7M $6.43 11